Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JDB0131 EBA, Safety, and PK in Drug-Sensitive Pulmonary Tuberculosis
NCT06224036Phase 2Recruiting
- Sponsor
- Beijing Chest Hospital
- Start
- Oct 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JDB0131 in pulmonary tuberculosis (TB), sponsored by Beijing Chest Hospital. Started Oct 2023; status: recruiting.
02
Drugs
JDB0131
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT06224036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06224036.